PHKG2 and neoplasm: In addition, RT-qPCR and immunohistochemistry results displayed that PHKG2 expression was significantly higher in the pre-radiotherapy tumor tissues from radiotherapy-sensitive NSCLC patients than in those from radiotherapy-resistant NSCLC patients (Fig. 1H, I), suggesting that high PHKG2 expression correlated with patients’ radiosensitivity.